was

Epi & Biostat -

StudyyFoerace
#dead of
mortality rate
crosssectional
:

total pop

o followed over time "snapshot" of time

Case fatality: dead

Cohort inceder,isease
from disease
ppl sick identified
by exposure to disease
followed over the
years

Case control
ansimbi. YNt Yay" Weights worco-odroot wl disease to guyis
Comparesgroup

ithadthis sold canceriginating

prevalence - cross-sect
survey
-C*(alive)
L

allinrent
OR (case control study)
n/c=ad entire
=

cases
pop.
odds diseased exposed

odds ratio Odds controls exposed

4
prevalence incidence Duration a
=
·

a >prevention)

RR relative risk - Prevalence

= (ath)

Incidence[cohort
C
->
Absolute study in

ctatc
risk ↑

aaD Atfibutable isals /osick

people at Risk death

a sick urarisk
-
you

Prevalence vs Incedence
PARE CARR) of exposure in 400. accepted:<10%
Prevalence Incidence Duration &
population
-

attributable risk Prevalence -- Incidence 4 Duration &

RRR =
1 RR relative Risk reduction
Attack Rate:sped 100
up-1p
Up

ARR= Cd- AbsOARR=FonooFcu,duction

I % Deci

68 16 peril
ISD
NNT=//ARR # need to treat
ONLY A) in denominator gy 2.5 perile
2SD

NIH //AR 3SD 99 5 PerYz

=

#needed to harm

Mean:sum of values
total of values

Median middle value (in order

=
least-> greatest

mode Bust
-

common
--

Drug
 I % Deci
Standard Deviation
68 16 peril
ISD & =
&)x-x)"
gy 2.5 perile 1-1
2SD
S

3SD 99.5 perc offclatin

Normal distribution
Variance
F

68% 1l
8
[(x-xT
=

H-I
05%=2
99% I3

ARP=CRRT)IRAincent

greater

Tail
↓

greater

Tail
b